Quick Heal Technologies
BSE 539678
3 stories, newest first.
- Quick Heal schedules Q2/H1 FY 2026-27 earnings call for 28 October 2026
- Board meeting on October 27, 2026 to approve unaudited results for Q2 and H1 of FY2026-27
- Shareholders Approve Re-appointment of Richard Stiennon as Non-Executive Independent Director for Second 5-Year Term
Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.